Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys Serving U.S. Outlying Islands: The Definitive Guide for Women and Families

For women and residents of the U.S. Outlying Islands who have undergone breast reconstruction, revision, or cosmetic augmentation, the discovery of a medical device failure is a moment of profound isolation. Because the U.S. Outlying Islands are geographically remote, patients stationed or living here often travel thousands of miles to medical hubs in Honolulu, Los Angeles, or San Francisco for specialized surgical care. When that care involves the implantation of defective acellular dermal matrix (ADM), bioabsorbable scaffolds like GalaFLEX, or textured surgical mesh, the physical and emotional fallout is devastating. At The Manginello Law Firm, PLLC, operating under our consumer brand Attorney911, we recognize that for a woman in the U.S. Outlying Islands, a diagnosis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) or a systemic infection related to defective mesh is not just a medical crisis—it is a logistical and legal one.

We represent victims of defective medical devices with a level of substantive command that generalist firms cannot match. Led by our managing partner, Ralph Manginello, who has been licensed for 27 continuous years and is admitted to the United States District Court for the Southern District of Texas (Bar Card No. 24007597), we bring a hyper-scientific approach to product liability. We understand that the “internal bra” technique and ADM-assisted reconstruction were marketed as the gold standard, yet many of these devices entered the market through the FDA 510(k) clearance pathway without ever being proven safe for use in human breast tissue. If you are in the U.S. Outlying Islands and believe your recent complications—including red breast syndrome, chronic infection, or a cancer diagnosis—are linked to a defective implant or scaffold, call us at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-cost consultation.

The Access-and-Travel Reality for U.S. Outlying Islands Patients

Living or working in the U.S. Outlying Islands requires a unique level of resilience, particularly when dealing with the U.S. healthcare system’s failures. Whether you are on Midway Atoll, Wake Island, or Palmyra Atoll, your surgical procedures likely took place at major tertiary referral centers on the mainland or in Hawaii. This distance often complicates the process of obtaining operative reports and device implant stickers—the critical “Unique Device Identifiers” (UDI) required to build a case. Our firm, including associate attorney Lupe Peña, understands the complexities of multi-state litigation and federal court venues. Lupe Peña, a third-generation Texan licensed since 2012, brings a distinct advantage to our clients: she previously worked in insurance defense. We know exactly how device manufacturers and their insurers attempt to minimize injuries to women from the U.S. Outlying Islands by blaming “surgical technique” rather than defective product design. We use our insider knowledge of the insurance industry to anticipate their moves before they make them.

Because the U.S. Outlying Islands are under federal jurisdiction, your case may traverse different federal districts depending on where the surgery was performed and where the manufacturer is headquartered. We are currently lead counsel in Bermudez v. Pi Kappa Phi Fraternity, Inc., et al., a high-profile $10,000,000 litigation in Harris County, Texas. This case demonstrates our ability to prosecute complex, multi-defendant institutional liability claims—the exact structural profile needed to take on multibillion-dollar medical device companies like Becton Dickinson (BD), Allergan, and Johnson & Johnson. If you are a resident of the U.S. Outlying Islands suffering from a failed reconstruction, we provide the aggressive advocacy necessary to secure the maximum compensation for your travel, medical bills, and permanent disfigurement.

Understanding the Defective Device Landscape: ADM, Scaffolds, and Mesh

For many patients in the U.S. Outlying Islands, the terms “Acellular Dermal Matrix” or “Bioabsorbable Scaffold” were likely introduced by a surgeon as a way to “support” or “reinforce” the reconstruction. In reality, many of these products were never cleared for use in the breast. We examine the specific brands and materials that have caused widespread harm across the U.S. Outlying Islands patient community.

Acellular Dermal Matrix (ADM)

ADM is a biologic material, often derived from human cadaver skin or porcine (pig) tissue, that has been processed to remove cells while leaving the structural collagen matrix. Products like AlloDerm (Allergan/AbbVie), Strattice, FlexHD, and AlloMax (C.R. Bard/BD) have been used extensively in “off-label” breast procedures. The FDA’s March 31, 2021, Safety Communication explicitly warned that FlexHD and AlloMax were associated with significantly higher rates of explantation, reoperation, and infection. For a patient traveling from the U.S. Outlying Islands for treatment, an unexpected reoperation at a mainland hospital can be financially and physically catastrophic.

Bioabsorbable Synthetic Scaffolds

Scaffolds like GalaFLEX (Galatea Surgical/BD) and Phasix Mesh are made of poly-4-hydroxybutyrate (P4HB). These synthetic materials are supposed to be resorbed by the body over 18 to 24 months. However, we have seen cases where the material fails to resorb, leading to palpable mesh edges, chronic inflammation, and breast ptosis (bottoming out). The FDA issued a critical letter to healthcare providers on November 9, 2023, stating that “no surgical mesh products have been cleared or approved by the FDA for use in breast surgery.” This includes the GalaFLEX line used in many U.S. Outlying Islands patient reconstructions. Ralph Manginello and our team are closely monitoring the litigation in Rhode Island state court and federal venues where GalaFLEX failures are being prosecuted.

Textured Silicone and BIA-ALCL

The July 2019 recall of Allergan BIOCELL textured implants remains a central concern for women in the U.S. Outlying Islands. These implants are six times more likely to cause BIA-ALCL—a CD30-positive, ALK-negative T-cell lymphoma—than other textured devices. If you were stationed in the U.S. Outlying Islands and received these recalled devices, you may already be part of a group of thousands seeking justice in MDL 2921 before Judge Brian R. Martinotti. Our firm handles the complex coordination required for these mass torts, ensuring that patients in remote locations like the U.S. Outlying Islands are never left behind in the settlement process.

The 510(k) Regulatory Failure: A “Substantial Equivalence” Trap

Most patients from the U.S. Outlying Islands believe that if a device is in a surgeon’s hand, it must be “FDA Approved.” This is a dangerous misconception. Most breast mesh and ADM products entered the market through the 510(k) clearance pathway (21 CFR Part 807 Subpart E). Unlike the Premarket Approval (PMA) process (21 CFR Part 814), 510(k) only requires the manufacturer to show that a device is “substantially equivalent” to a “predicate device” that was already on the market.

We have documented what we call “predicate creep.” For example, the manufacturer of GalaFLEX mesh cited a surgical suture as one of its predicates. A suture is not a mesh, yet the FDA allowed this shortcut. Under the landmark Supreme Court case Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996), 510(k) clearance does not preempt state-law product liability claims. This means you can still sue the manufacturer even if the FDA “cleared” the device. Ralph Manginello has been navigating these complex doctrinal frameworks for decades, ensuring that our clients in the U.S. Outlying Islands have a path to recovery that cannot be blocked by corporate legal maneuvers.

By contrast, Class III devices with PMA approval are often subject to “preemption” under Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), which can limit a plaintiff’s ability to sue. Because we focus on the specific section numbers and regulatory paths (21 CFR §803 for Medical Device Reporting), we know how to thread the needle to ensure your case survives a motion to dismiss. If you are in the U.S. Outlying Islands and were told you “signed a waiver,” do not believe that your rights are gone. Call us at 1-888-ATTY-911 for a real analysis of your legal standing.

Complications and Warning Signs for U.S. Outlying Islands Residents

Because specialty follow-up care is miles away from the U.S. Outlying Islands, it is vital to recognize the symptoms of a defective mesh or scaffold failure immediately. If you experience any of the following, seek medical attention and then contact Attorney911.

• Red Breast Syndrome (RBS): A noninfectious, sterile inflammation specific to ADM. This is often caused by bacterial endotoxins (lipopolysaccharides) retained on the matrix even after sterilization.
• Late-Onset Seroma: A collection of fluid around the implant occurring years after surgery. For patients in the U.S. Outlying Islands, a late seroma is a primary warning sign for BIA-ALCL, which requires specialized CD30+/ALK- pathology testing.
• BIA-SCC (Squamous Cell Carcinoma): An emerging epithelial tumor identified in implant capsules. The FDA updated its safety communication on this in March 2023 after documenting deaths linked to this specific malignancy.
• Skin-Flap Necrosis: The death of breast tissue overlying the matrix, often leading to mesh extrusion or total reconstruction failure.
• Breast Implant Illness (BII): A constellation of systemic symptoms including fatigue, joint pain, hair loss, and cognitive dysfunction (“brain fog”).

When Lupe Peña consults with women from the U.S. Outlying Islands, she listens for these systemic patterns. Her experience in insurance defense means she knows that companies will try to label these as “autoimmune issues” unrelated to their product. We use peer-reviewed clinical data to prove the inflammatory mechanism of the device is the proximate cause of your pain.

The Whistleblower Evidence: Dr. Hooman Noorchashm and GalaFLEX

A critical component of our litigation strategy involves the testimony of whistleblowers like Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson, Dr. Noorchashm was reportedly terminated in 2022 after raising safety concerns about how GalaFLEX was being marketed. He has publicly alleged that breast cancer recurrences in BD’s GalaFLEX clinical trials were withheld from the FDA.

For the breast cancer survivors in the U.S. Outlying Islands, this is the most alarming allegation: that a device meant to assist in your recovery may actually obscure the detection of a recurrence or contribute to an inflammatory environment that puts you at further risk. We incorporate this investigative authority into our claims, arguing that manufacturers like BD engaged in fraudulent concealment of failure data. When you hire Ralph Manginello, you are hiring a firm that stays at the forefront of these disclosures to hold manufacturers accountable.

Why Attorney911 Is the Choice for U.S. Outlying Islands Families

When you are facing a medical crisis in a remote location like the U.S. Outlying Islands, you need a firm with a massive public footprint and verified high-profile capability. Our firm doesn’t just “handle cases”—we teach the law. Ralph Manginello hosts the Attorney 911 podcast (Apple Podcasts ID 1773141988), with over 56 episodes dedicated to educating the public on their rights. Our social media presence across YouTube (@Manginellolawfirm) and Instagram (@attorney911) provides a transparent look at our commitment to the community.

Our E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) is verified by independent third parties:

• Avvo Rating 8.2/10 (Excellent) and a perfect 5.0/5.0 Client Review Score for Ralph Manginello.
• Martindale-Hubbell Preeminent 5.0 of 5.0 rating.
• BBB Accredited under the Houston Personal Injury Lawyer category (ID 0915-58003169).
• Member of the Pro Bono College of the State Bar of Texas, a recognition for attorneys like Ralph Manginello who provide at least 75 hours of pro bono service annually.

We understand that for many residents in the U.S. Outlying Islands, there may be language barriers. Hablamos español. Lupe Peña conducts full client consultations in fluent Spanish, ensuring that your story is heard directly by your attorney, not filtered through an interpreter. This direct communication is vital when discussing the sensitive medical details of a breast mesh injury.

Financial Recovery and Your Rights in the U.S. Outlying Islands

We work on a contingency-fee basis. This means if you are a resident of the U.S. Outlying Islands, you pay us nothing upfront. We only recover our fees if we successfully secure compensation for you. This “no win, no fee” structure allows women in the U.S. Outlying Islands to go toe-to-toe with multibillion-dollar corporations without financial risk.

Recoverable damages for U.S. Outlying Islands patients typically include:

1. Medical Expenses: The cost of explant surgery, revision procedures, and the travel required from the U.S. Outlying Islands to medical hubs.
2. Lost Wages: Income lost during recovery and travel for specialist care.
3. Non-Economic Damages: Pain and suffering, permanent disfigurement, and loss of enjoyment of life.
4. Loss of Consortium: The impact of your injury on your relationship with your spouse or partner.

Our firm has recovered over $50,000,000 for our clients. While every case is different, our success in cases like the Bermudez v. Pi Kappa Phi fraternity hazing litigation—where we are seeking $10,000,000 against 13 defendants—proves that we are not afraid to litigate against powerful institutions.

Frequently Asked Questions for U.S. Outlying Islands Residents

1. Is surgical mesh actually approved for breast surgery?
No. As the FDA stated in November 2023, the safety and effectiveness of surgical mesh in breast surgery has not been determined. Products like GalaFLEX and Phasix are used “off-label” in the U.S. Outlying Islands and elsewhere.

2. I live in the U.S. Outlying Islands but had my surgery in Honolulu. Where do I file?
Jurisdiction and venue are complex. Depending on the manufacturer’s location and where the harm occurred, we may file in the state of your surgery or in federal court. We handle the jurisdictional analysis for you.

3. What is the statute of limitations for U.S. Outlying Islands residents?
Since the U.S. Outlying Islands are federal territories, the law of the state where your surgery occurred or the state where the manufacturer is located usually governs. Most states have a 2-year statute of limitations from the date of discovery. Call 1-888-ATTY-911 immediately to verify your deadline.

4. How do I find out what brand of mesh was used?
You must request your full operative report and “Implant Log” from the hospital. Look for “UDI” stickers or lot numbers. We can assist U.S. Outlying Islands patients in obtaining these records through formal legal requests.

5. Can I still sue if my mesh is bioabsorbable?
Yes. “Bioabsorbable” does not mean safe. Many scaffolds like GalaFLEX cause chronic inflammatory reactions and fail to dissolve as promised, leading to permanent injury.

6. I had my surgery 8 years ago. Is it too late?
Not necessarily. Under the “discovery rule,” your time to file may only start when you first learned your injury was caused by the mesh. The FDA’s 2023 warning letter often serves as a “trigger” for this discovery.

7. Is this a class action?
No. These are typically individual product liability lawsuits. While cases may be consolidated into an MDL (Multidistrict Litigation) for efficiency, your settlement is based on your specific injuries.

8. What is “Red Breast Syndrome”?
It is a sterile (non-infectious) redness of the breast caused by a reaction to an Acellular Dermal Matrix (ADM). It is a recognized complication in the medical literature.

9. Can I sue for Breast Implant Illness (BII)?
Yes. While BII is a constellation of symptoms, many courts are now recognizing these claims, especially when linked to the failure of the device’s shell or the matrix used to support it.

10. What did Dr. Hooman Noorchashm reveal about GalaFLEX?
He alleged that Becton Dickinson withheld information regarding breast cancer recurrences in patients who received GalaFLEX during reconstruction.

11. Who is the primary manufacturer of GalaFLEX?
Becton Dickinson (BD), which acquired Galatea Surgical and Tepha Inc.

12. Does Attorney911 have experience in major litigation?
Yes. We are current counsel in the Bermudez v. Pi Kappa Phi fraternity hazing case, a high-stakes $10 million litigation covered by major news outlets like FOX 26 and ABC13.

13. What happens if I am diagnosed with BIA-ALCL?
BIA-ALCL is a serious cancer. You likely have a claim against the implant manufacturer (such as Allergan) and potentially the matrix manufacturer if a textured mesh was used.

14. What if I can’t afford an attorney?
We work on contingency. No fee unless we recover. Call 1-888-ATTY-911 for a free case evaluation.

15. Is Lupe Peña really a former insurance defense lawyer?
Yes. Lupe brings over a decade of experience and uses the tactics she learned “on the other side” to fight for victims in the U.S. Outlying Islands.

16. Does Ralph Manginello personally handle these cases?
Ralph is the Managing Partner and oversees the firm’s strategy on all massive product liability claims.

17. What is 510(k) clearance?
It is a regulatory shortcut that allows manufacturers to sell devices without proving safety, only that they are “equivalent” to an older device.

18. What if my surgeon said the mesh was safe?
The “Learned Intermediary Doctrine” often protects surgeons, but if the manufacturer lied to the surgeon about the product’s safety, the manufacturer is liable.

19. Can I recover for my travel from the U.S. Outlying Islands?
Yes. In a product liability suit, the total economic impact—including medical travel and airfare for revision surgeries—is part of your claim.

20. Will my case go to trial?
Most defective device cases settle before trial, but we prepare every case as if it is going to a jury to ensure the highest settlement value.

21. Where is the principal office of Attorney911?
Our main office is at 1177 West Loop South, Suite 1600, Houston, TX 77027, but we represent clients in federal cases nationwide.

22. How do I start?
Call 1-888-ATTY-911 or contact us through our website at attorney911.com.

23. Is the firm recognized for ethics?
Yes. Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, and the firm holds a 4.9/5.0 star rating on Birdeye across hundreds of reviews.

24. Can I get a second opinion on my legal case?
Yes. If you have another lawyer but feel they don’t understand the science of ADM or BIA-ALCL, you have the right to switch counsel.

25. Do you handle wrongful death cases for families in the U.S. Outlying Islands?
Yes. If you lost a loved one to sepsis or device-related cancer, we prosecute wrongful death claims aggressively.

Evidence Preservation for Patients and Families

If you are a resident of the U.S. Outlying Islands and believe you have a claim, the preservation of evidence is your first priority.

• Request the “Device Stickers”: Every implant or mesh comes with a tracer sticker. Ensure these are in your permanent file.
• Keep the Explanted Device: If you have surgery to remove the mesh or implant, you have the right to keep it. Do not let the hospital return it to the manufacturer for “testing” without your attorney present.
• Document Symptoms: Take photographs of swelling, redness, or asymmetry. Keep a daily journal of your pain levels.
• Preserve Financial Records: Save every receipt for flights from the U.S. Outlying Islands to your medical provider.

Take the First Step with Attorney911

The path to justice for women in the U.S. Outlying Islands starts with a single phone call. You have been through enough—the surgery, the cancer, the complications, and the isolation of your geographic location. You deserve a law firm that treats you with the dignity of a survivor and the precision of a scientist.

Ralph Manginello, Lupe Peña, and the entire team at The Manginello Law Firm, PLLC are ready to help. Whether you are dealing with a failed reconstruction, a BIA-ALCL diagnosis, or the discovery that your implants are on the recall list, we provide the aggressive, compassionate representation you need.

Call 1-888-ATTY-911 (1-888-288-9911) today. We represent victims in the U.S. Outlying Islands on a contingency-fee basis—no fee unless we recover for you. Case expenses may apply. Si usted ha sido lesionado por una malla quirúrgica o implantes defectuosos, nuestro equipo bilingüe está aquí para ayudarle.

Your health, your family, and your future are too important to leave to a generalist. Choose the firm that understands the science, knows the insurance industry’s secrets, and has a proven record of winning major litigation. Choose Attorney911.

Past results do not guarantee future outcomes. The information provided on this page is for educational purposes and does not originate an attorney-client relationship. Every case is unique and depends on specific facts and jurisdictional law. For legal advice regarding your situation in the U.S. Outlying Islands, contact us for a confidential consultation.